Thromb Haemost 1994; 72(05): 693-697
DOI: 10.1055/s-0038-1648944
Original Article
Schattauer GmbH Stuttgart

Construction and Characterization of Thrombin-resistant Variants of Recombinant Human Protein S

Glenn T G Chang
1   The Department of Haematology, University Hospital Utrecht, The Netherlands
,
Leonie Aaldering
1   The Department of Haematology, University Hospital Utrecht, The Netherlands
,
Tilman M Hackeng
1   The Department of Haematology, University Hospital Utrecht, The Netherlands
,
Pieter H Reitsma
2   Thrombosis and Haemostasis Research Centre, Department of Haematology, Leiden University Hospital, The Netherlands
,
Rogier M Bertina
2   Thrombosis and Haemostasis Research Centre, Department of Haematology, Leiden University Hospital, The Netherlands
,
Bonno N Bouma
1   The Department of Haematology, University Hospital Utrecht, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 06 January 1994

Accepted after resubmission 12 July 1994

Publication Date:
26 July 2018 (online)

Summary

Protein S is a vitamin K-dependent plasma protein that functions as a cofactor of activated protein C (APC) in the inactivation of coagulation factors Va and Villa.

Protein S, migrates as a doublet on reduced SDS polyacrylamide gel electrophoresis. This heterogeneity in molecular weight has been explained by limited proteolysis of protein S. Human protein S contains at Arg-49, Arg-60 and Arg-70 three potential cleavage sites. Whether cleavage occurs at all three sites is not known. To study the role of these arginine residues in human protein S, we have replaced them by leucine or isoleucine. All seven possible variants were constructed: three variants with single mutations (R49L, R60L, R70I), three variants with double mutations (R49L/R60L, R60L/R70I, R49L/R70I) and one variant with a triple mutation (R49L/R60L/R70I). On reduced SDS polyacrylamide gels the single and double variants migrate as a doublet just like the wild type protein S. The triple variant migrates as a single band at a molecular weight corresponding to the upper band of the doublet. The upper band of the single and double variants but not of the triple variant could be converted into the lower band by thrombin treatment.

All variants showed cofactor activity to APC in a clotting assay. After thrombin treatment, this cofactor activity was abolished for the single (R49L, R60L, R70I) and double variants (R49L/R60L, R60L/R70I, R49L/R70I), while the triple variant (R49L/R60L/R70I) tested at several concentrations, retained its cofactor activity completely, suggesting resistance to thrombin. This shows that thrombin can cleave at all three arginine sites and that cleavage at each of these sites results in the loss of APC cofactor activity. Finally, all variants bind to C4b-binding protein with an affinity similar as the wild type recombinant molecule.

 
  • References

  • 1 DiScipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, Factor IX (Christmas Factor), Factor X (Stuart Factor), and protein S. Biochemistry 1977; 16: 698-706
  • 2 DiScipio RG, Davie EW. Characterization of protein S, a γ-carboxyglutamic acid containing protein from bovine and human plasma. Biochemistry 1979; 18: 899-904
  • 3 Dahlback B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-12027
  • 4 Bertina RM, Ploos van Amstel HK, van Wijngaarden A, Coenen J, Leemhuis MP, Deutz-Terlouw PP, van der Linden IK, Reitsma PH. Heerlen polymorphism of proteinS, an immunologic polymorphism due to dimorphism of residue 460. Blood 1990; 76: 538-548
  • 5 Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-5524
  • 6 Gardiner JE, McGann MA, Berridge CW, Fulcher CA, Zimmerman TS, Griffin JH. Protein S as a cofactor for activated protein C in plasma and in the inactivation of purified factor VIII: C. Circulation 1984 70. II-205 abstract
  • 7 Koedam JA, Meijers JCM, Sixma JJ, Bouma BN. Inactivation of human factor VIII by activated protein C. Cofactor activity of proteinS and protective effect of von Willebrand factor. J Clin Invest 1988; 82: 1236-1243
  • 8 Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-2088
  • 9 Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300
  • 10 Engesser L, Broekmans AW, Briet E, Brommer EJ, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106: 677-682
  • 11 Dahlback B, Lundwall A, Stenflo J. Primary structure of bovine vitamin K-dependent protein S. Proc Natl Acad Sci USA 1986; 83: 4199-4203
  • 12 Lundwall A, Dackowski W, Cohen E, Shaffer M, Mahr A, Dahlback B, Stenflo J, Wydro R. Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation. Proc Natl Acad Sci USA 1986; 83: 6716-6720
  • 13 Hoskins J, Norman DK, Beckmann RJ, Long GL. Cloning and characterization of human liver cDNA encoding a protein S precursor. Proc Natl Acad Sci USA 1987; 84: 349-353
  • 14 Ploos van Amstel JK, van der Zanden AL, Bakker E, Reitsma PH, Bertina RM. Two genes homologous with human protein S cDNA are located on chromosome 3. Thromb Haemost 1987; 58: 982-987
  • 15 Mitchell CA, Hau L, Salem HH. Control of thrombin mediated cleavage of protein S. Thromb Haemost 1986; 56: 151-154
  • 16 Dahlback B, Lundwall A, Stenflo J. Localization of thrombin cleavage sites in the amino-terminal region of bovine protein S. J Biol Chem 1986; 261: 5111-5115
  • 17 Dahlback B. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J 1983; 209: 837-846
  • 18 Morita T, Mizuguchi J, Kawabata S, Iwanaga S. Proteolytic cleavage of vitamin K-dependent bovine plasma protein S by α-thrombin and plasma serine protease. J Biochem Tokyo 1986; 99: 561-568
  • 19 Walker FJ. Regulation of vitamin K-dependent protein S. Inactivation by thrombin. J Biol Chem 1984; 259: 10335-10339
  • 20 Suzuki K, Nishioka J, Hashimoto S. Regulation of activated protein C by thrombin-modified protein S. J Biochem Tokyo 1983; 94: 699-705
  • 21 Hessing M, Vlooswijk RAA, Hackeng TM, Kanters D, Bouma BN. The localization of heparin-binding fragments on human C4b-binding protein. J Immunol 1990; 144: 204-208
  • 22 Sambrook J, Fritz EF, Maniatis T. Molecular Cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor; New York: 1989
  • 23 Chang GTG, Ploos van Amstel HK, Hessing M, Reitsma PH, Bertina RM, Bouma BN. Expression and characterization of recombinant human protein S in heterologous cells - Studies of the interaction of amino acid residues Leu-608 to Glu-612 with human C4b-binding protein. Thromb Haemost 1992; 67: 526-532
  • 24 Kunkel TA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 1985; 82: 488-492
  • 25 Sanger F, Nicklen S, Coulson AR. DNA sequening with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 76: 5463-5467
  • 26 Graham F, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus. Virology 1983; 52: 456-467
  • 27 Grinnell BW, Walls JD, Marks C, Glasebrook AL, Berg DT, Yan BS, Bang NU. γ-Carboxylated isoforms of recombinant human protein S with different biologic properties. Blood 1990; 76: 2546-2554
  • 28 Deutz-Terlouw PP, Ballering L, van Wijngaarden A, Bertina RM. Two ELISA’s for measurement of protein S and their use in the laboratory diagnosis of protein S deficiency. Clin Chim Acta 1989; 186: 321-334